Literature DB >> 20401594

Measuring the activity of active efflux in gram-negative bacteria.

Mark A Webber1, Nick G Coldham.   

Abstract

Resistance to clinically useful therapeutic antibiotics is an ever-increasing phenomenon seen in a range of bacterial species including those pathogenic to man. There are diverse mechanisms which contribute to inherent and acquired resistance to antibiotics. Gram-negative bacteria are commonly intrinsically more resistant to many drugs as a result of their cell structure and the activity of multidrug efflux pumps. Measurement of the accumulation of antibiotics and the contribution of active efflux has proved important in understanding the mechanisms of resistance to many antibiotics and how bacteria can become multidrug-resistant. Multidrug efflux pumps often have broad substrate ranges allowing detection of their activity by measurement of the accumulation of antibiotic substrates or a range of fluorescent substrates, which can be easily used as markers of efflux activity. This chapter describes methods for the detection of efflux pump activity on Gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401594     DOI: 10.1007/978-1-60327-279-7_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Alternative explanation for indole-induced antibiotic tolerance in Salmonella.

Authors:  Jessica M A Blair; Axel Cloeckaert; Kunihiko Nishino; Laura J V Piddock
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-06       Impact factor: 11.205

2.  Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli.

Authors:  Manish Goswami; Mahesh Subramanian; Ranjeet Kumar; Jana Jass; Narendra Jawali
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

3.  Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step.

Authors:  Rebekah N Whitehead; Tim W Overton; Caroline L Kemp; Mark A Webber
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.